Concourse Financial Group Securities’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10379 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10140 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 9905 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 9657 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 9437 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 9079 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 9088 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 8895 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8726 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8526 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8239 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 7807 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7445 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7126 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6840 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6592 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6426 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6321 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6235 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6082 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6072 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5951 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 5866 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5713 |
|